Clinical Trials Directory

Trials / Unknown

UnknownNCT05995418

Study on the Health Economic Burden of Alzheimer's Disease in China

Monetary Costs of Alzheimer's Disease in China: Protocol for a Cluster-randomized Observational Study

Status
Unknown
Phase
Study type
Observational
Enrollment
9,510 (estimated)
Sponsor
Xuanwu Hospital, Beijing · Academic / Other
Sex
All
Age
40 Years – 100 Years
Healthy volunteers
Not accepted

Summary

This study is a multi-center and cross-sectional study. Using standardized case report forms, we randomly selected suitable patients from the cognitive centers of provincial administrative units in Chinese mainland to conduct a questionnaire survey, so as to obtain relevant information about their economic burden.

Detailed description

Under the policy background of building a national cognitive center, this study collected and evaluated the socio-demographic characteristics, geographical location, regional socio-economic development level, family support, medical resources, related behaviors, nursing environment, patients' health behaviors, current medical history, past history, drug use, family history and clinical diagnosis of Alzheimer's patients in inland provinces and cities of China, and made statistics on the related information of patients' health economics. To form a comprehensive assessment of the health economic burden of Alzheimer's disease in China, the primary objectives of the study are as follows: 1. Comprehensively assess the health economic burden of Alzheimer's disease, including medical and non-medical costs. 2. Explore the economic burden of Alzheimer's disease in different stages, including mild cognitive impairment stage, mild to moderate Alzheimer's disease stage and severe Alzheimer's disease stage. 3. To explore the health economic burden of the comorbidity of Alzheimer's disease and other chronic diseases.

Conditions

Interventions

TypeNameDescription
OTHERThere was no intervention as this was an observational study.There was no intervention as this was an observational study.

Timeline

Start date
2023-07-01
Primary completion
2024-04-01
Completion
2024-08-01
First posted
2023-08-16
Last updated
2023-08-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05995418. Inclusion in this directory is not an endorsement.